HAEMONETICS CORPORATION (NYSE:HAE) Files An 8-K Results of Operations and Financial ConditionItem 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION
HAEMONETICS CORPORATION (NYSE:HAE) Files An 8-K Results of Operations and Financial Condition
On May 8, 2017, Haemonetics Corporation (the “Company”) issued a press release announcing financial results for the fourth quarter>ended April 1, 2017. A copy of the release is furnished with this report as exhibit 99.1.
The information in this current report on Form 8-K and the exhibit attached hereto shall not be deemed “filed” for the purposes of Section 18 of the Securities and Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, regardless of any general incorporation language in such filing.
Item 9.01 FINANCIAL STATEMENTS AND EXHIBITS
99.1: Press Release of Haemonetics Corporation dated May 8, 2017>announcing financial results for the fourth quarter>ended April 1, 2017.
About HAEMONETICS CORPORATION (NYSE:HAE)
Haemonetics Corporation (Haemonetics) is a healthcare company. The Company provides various products to customers involved in the processing, handling and analysis of blood. The Company’s segments include Japan, EMEA, North America Plasma and All Other. Haemonetics provides plasma collection systems and software, which enable plasma fractionators to make pharmaceuticals. The Company enables plasma collection customers to source from it a range of products necessary for plasma collection and storage, including PCS brand plasma collection equipment and disposables, plasma collection containers and intravenous solutions, such as saline. Haemonetics offers automated blood component and manual whole blood collection systems to blood collection centers to collect blood products. The Company offers a range of blood management solutions. The Company has a suite of integrated software solutions, which include solutions for blood drive planning and blood collection. HAEMONETICS CORPORATION (NYSE:HAE) Recent Trading Information
HAEMONETICS CORPORATION (NYSE:HAE) closed its last trading session up +0.87 at 43.20 with 432,517 shares trading hands.
Haemonetics Corporation (Haemonetics) is a healthcare company. The Company provides various products to customers involved in the processing, handling and analysis of blood. The Company’s segments include Japan, EMEA, North America Plasma and All Other. Haemonetics provides plasma collection systems and software, which enable plasma fractionators to make pharmaceuticals. The Company enables plasma collection customers to source from it a range of products necessary for plasma collection and storage, including PCS brand plasma collection equipment and disposables, plasma collection containers and intravenous solutions, such as saline. Haemonetics offers automated blood component and manual whole blood collection systems to blood collection centers to collect blood products. The Company offers a range of blood management solutions. The Company has a suite of integrated software solutions, which include solutions for blood drive planning and blood collection. HAEMONETICS CORPORATION (NYSE:HAE) Recent Trading Information
HAEMONETICS CORPORATION (NYSE:HAE) closed its last trading session up +0.87 at 43.20 with 432,517 shares trading hands.